A-10. アンジオテンシンII拮抗性ペプチドの臨床応用

Two angiotensin H analogues are now available in clinical study. Comparative studies of the antagonistic potency and the agonisic effect between these two analogues, i. e., [1-Sarcosine, 8-Isoleusine] angiotensin II and [1-Sarcosine, 8-Alanine] angiotensin II, were done in normal subjects on various...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the Symposium on Chemical Physiology and Pathology Vol. 17; pp. 49 - 53
Main Authors 中丸, 光昭, 萬代, 隆, 波多, 丈, 三上, 洋, 熊原, 雄一, 荻原, 俊男
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本臨床化学会 1978
Japan Society of Clinical Chemistry
Online AccessGet full text
ISSN0386-3417
2187-4085
DOI10.14921/jscc1971a.17.0_49

Cover

Abstract Two angiotensin H analogues are now available in clinical study. Comparative studies of the antagonistic potency and the agonisic effect between these two analogues, i. e., [1-Sarcosine, 8-Isoleusine] angiotensin II and [1-Sarcosine, 8-Alanine] angiotensin II, were done in normal subjects on various sodium balances and in hypertensives on sodium depletion. Both analogues had an agonistic pressor effect in normals. There was found agonistic effects in both compounds not only on blood pressure, but also renin and aldosterone secretion and creatinine clearance in normal subjects on regular diet. The agonistic pressor effects changed with different sodium balances. In low sodium phase, these pressor effects were minimized. Agonistic effect of [1-Sar, 8-Ile] A II was greater than that of [1-Sar, 8-Ala] A II in all sodium balances. The antagonistic effects of both compounds were also varied by changing sodium balance, being greatest in low sodium phase. In hypertensives on sodium depletion, blood pressure responses (δBP) to these A II analogues were significantly correlated (r=0.8, n=20). These results indicate that pretreatment of sodium depletion is necessary to prevent the side effects caused by agonistic pressor effects of these analogues, and also to predict renin dependency in hypertensive patiens efficiently.Results of clinical application of [1-Sar, 8-Ile] A II are as follows:(1) This compound showed a pressor response in low reninemic state, and a depressor response in some cases with high plasma renin activity (PRA). There was a negative correlation between pre-infusion PRA and change in blood pressure following the infusion of this compound. In most high reninemic patients, a depressor response was observed after sodium depletion.(2) In subjects with Cushing's syndrome and pheochromocytoma, a marked pressor response was observed.(3)[1-Sar, 8-Ile] A II reduced blood pressure in a part of normotensive secondary aldosteronism, such as liver cirrhosis with ascites, Bartter's syndrome, congestive heart failure and renal tubular acidosis, and a case of Addison's disease.(4) Subjects taking oral contraceptives with or without hypertension showed no reduction of blood pressure in our limited study. These results indicate that R-A-A system play an important role in the maintenance of normal blood pressure in normotensive secondary aldosteronism and of high blood pressure in a part of high reninemic hypertension.Application of these A II inhibiting analogues should be useful for the understanding the role of R-A-A system in physiological and pathophysiological conditions in human.
AbstractList Two angiotensin H analogues are now available in clinical study. Comparative studies of the antagonistic potency and the agonisic effect between these two analogues, i. e., [1-Sarcosine, 8-Isoleusine] angiotensin II and [1-Sarcosine, 8-Alanine] angiotensin II, were done in normal subjects on various sodium balances and in hypertensives on sodium depletion. Both analogues had an agonistic pressor effect in normals. There was found agonistic effects in both compounds not only on blood pressure, but also renin and aldosterone secretion and creatinine clearance in normal subjects on regular diet. The agonistic pressor effects changed with different sodium balances. In low sodium phase, these pressor effects were minimized. Agonistic effect of [1-Sar, 8-Ile] A II was greater than that of [1-Sar, 8-Ala] A II in all sodium balances. The antagonistic effects of both compounds were also varied by changing sodium balance, being greatest in low sodium phase. In hypertensives on sodium depletion, blood pressure responses (δBP) to these A II analogues were significantly correlated (r=0.8, n=20). These results indicate that pretreatment of sodium depletion is necessary to prevent the side effects caused by agonistic pressor effects of these analogues, and also to predict renin dependency in hypertensive patiens efficiently.Results of clinical application of [1-Sar, 8-Ile] A II are as follows:(1) This compound showed a pressor response in low reninemic state, and a depressor response in some cases with high plasma renin activity (PRA). There was a negative correlation between pre-infusion PRA and change in blood pressure following the infusion of this compound. In most high reninemic patients, a depressor response was observed after sodium depletion.(2) In subjects with Cushing's syndrome and pheochromocytoma, a marked pressor response was observed.(3)[1-Sar, 8-Ile] A II reduced blood pressure in a part of normotensive secondary aldosteronism, such as liver cirrhosis with ascites, Bartter's syndrome, congestive heart failure and renal tubular acidosis, and a case of Addison's disease.(4) Subjects taking oral contraceptives with or without hypertension showed no reduction of blood pressure in our limited study. These results indicate that R-A-A system play an important role in the maintenance of normal blood pressure in normotensive secondary aldosteronism and of high blood pressure in a part of high reninemic hypertension.Application of these A II inhibiting analogues should be useful for the understanding the role of R-A-A system in physiological and pathophysiological conditions in human.
Author 波多, 丈
三上, 洋
中丸, 光昭
熊原, 雄一
萬代, 隆
荻原, 俊男
Author_FL 荻原 俊男
萬代 隆
熊原 雄一
三上 洋
中丸 光昭
波多 丈
Author_FL_xml – sequence: 1
  fullname: 荻原 俊男
– sequence: 2
  fullname: 波多 丈
– sequence: 3
  fullname: 三上 洋
– sequence: 4
  fullname: 中丸 光昭
– sequence: 5
  fullname: 萬代 隆
– sequence: 6
  fullname: 熊原 雄一
Author_xml – sequence: 1
  fullname: 中丸, 光昭
  organization: 大阪大学医学部第四内科
– sequence: 1
  fullname: 萬代, 隆
  organization: 大阪大学医学部第四内科
– sequence: 1
  fullname: 波多, 丈
  organization: 大阪大学医学部第四内科
– sequence: 1
  fullname: 三上, 洋
  organization: 大阪大学医学部第四内科
– sequence: 1
  fullname: 熊原, 雄一
  organization: 大阪大学医学部第四内科
– sequence: 1
  fullname: 荻原, 俊男
  organization: 大阪大学医学部第四内科
BackLink https://cir.nii.ac.jp/crid/1390282679672677504$$DView record in CiNii
BookMark eNo9kL1KA0EUhQeJYIx5ASsL243zuzNTxvgXCNhoPczOTnSXGGU3jZ1mQTG2QkCsbAwWaSwUGx9mSPQxnBhJ890L99zDuXcVlLrnXQvAOoI1RCVGW2luDJIc6RriNaioXAJljAQPKBSsBMqQiDAgFPEVUM3zJIKQhlhgRMpgpx54mw3Xf3bFm-t_uP6rK27--nfPZnN6P54OhtOrF1c8umLoimtX3Lnr8c_taPI5mHw9fT-M1sByW3dyW_2vFXC8t3vUOAhah_vNRr0VpBghGpjQx4Shji2zPlKkI4tILGQsKOZSWKK55hRHsRe0DaOMSW0hhrbtF5ghpAI2577dJFEmmRERCf0pIZch9-QMUi_bnsvSvKdPrLrIkjOdXSqd9RLTsWrxLoW4gjNQuRiaU52pVJNfAj94wQ
ContentType Journal Article
Copyright 日本臨床化学会
Copyright_xml – notice: 日本臨床化学会
DBID RYH
DOI 10.14921/jscc1971a.17.0_49
DatabaseName CiNii Complete
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Clinical Application of Angiotensin II Analogues
DocumentTitle_FL Clinical Application of Angiotensin II Analogues
EISSN 2187-4085
EndPage 53
ExternalDocumentID 130003355126
article_jscc1971a_17_0_17_49_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
RYH
ID FETCH-LOGICAL-j2114-c6cc106ade5e038babe13d89d842798e3a7a742bdde5fc54559ae020efe5e5c33
ISSN 0386-3417
IngestDate Thu Jun 26 23:36:19 EDT 2025
Wed Sep 03 06:30:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2114-c6cc106ade5e038babe13d89d842798e3a7a742bdde5fc54559ae020efe5e5c33
OpenAccessLink https://www.jstage.jst.go.jp/article/jscc1971a/17/0/17_49/_article/-char/ja
PageCount 5
ParticipantIDs nii_cinii_1390282679672677504
jstage_primary_article_jscc1971a_17_0_17_49_article_char_ja
PublicationCentury 1900
PublicationDate 1978
PublicationDateYYYYMMDD 1978-01-01
PublicationDate_xml – year: 1978
  text: 1978
PublicationDecade 1970
PublicationTitle Proceedings of the Symposium on Chemical Physiology and Pathology
PublicationTitleAlternate 臨床化学シンポジウム
PublicationTitle_FL 臨床化学シンポジウム
PublicationYear 1978
Publisher 一般社団法人 日本臨床化学会
Japan Society of Clinical Chemistry
Publisher_xml – name: 一般社団法人 日本臨床化学会
– name: Japan Society of Clinical Chemistry
References 5) Ogihara, T., Hata, T., Mikami, H., Mandai, T. and Kumahara, Y.: Life Sciences, 20, 1855 (1977
2) Ogihara, T., Yamamoto, T. and Kumahara, Y.: Lancet, 1, 219 (1974
1) Brunner, H. D., Gavras, H. and Laragh, J. H.: Lancet, 2, 1045 (1973
3) Ogihara, T., Yamamoto, T. and Kumahara, Y.: Jap. Circul. J., 38, 997 (1974
4) Yamamoto, T., Ogihara, T., Kumahara, Y. and Hata, T.: J. Jap. Soc. Int. Med., 65, 464 (1976)(in Japanese
References_xml – reference: 5) Ogihara, T., Hata, T., Mikami, H., Mandai, T. and Kumahara, Y.: Life Sciences, 20, 1855 (1977)
– reference: 2) Ogihara, T., Yamamoto, T. and Kumahara, Y.: Lancet, 1, 219 (1974)
– reference: 1) Brunner, H. D., Gavras, H. and Laragh, J. H.: Lancet, 2, 1045 (1973)
– reference: 4) Yamamoto, T., Ogihara, T., Kumahara, Y. and Hata, T.: J. Jap. Soc. Int. Med., 65, 464 (1976)(in Japanese)
– reference: 3) Ogihara, T., Yamamoto, T. and Kumahara, Y.: Jap. Circul. J., 38, 997 (1974)
SSID ssib004628213
ssib025269818
ssj0003306182
Score 1.2364916
Snippet Two angiotensin H analogues are now available in clinical study. Comparative studies of the antagonistic potency and the agonisic effect between these two...
SourceID nii
jstage
SourceType Publisher
StartPage 49
Title A-10. アンジオテンシンII拮抗性ペプチドの臨床応用
URI https://www.jstage.jst.go.jp/article/jscc1971a/17/0/17_49/_article/-char/ja
https://cir.nii.ac.jp/crid/1390282679672677504
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 臨床化学シンポジウム, 1978/07/20, Vol.17, pp.49-53
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2187-4085
  dateEnd: 19821231
  omitProxy: true
  ssIdentifier: ssj0003306182
  issn: 0386-3417
  databaseCode: KQ8
  dateStart: 19720101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Pb9MwFI-2ceGCQIAYMNQDPqGWJk78R5zcNtOKBBLSJu0WJW4qtYcyQXfhxFoJxLgiTUKcuDBx2IUDiAvfhEu0wsfgvZek7egOG0iR9fT8bD_72fHvObHtOHetb7mXqBh8E5VWfS-xMKTw1lTVxe5sO5I2Cj96LDa2_IfbwfbS8s-5v5Z2h0nNvjh1X8m_WBV4YFfcJXsOy04zBQbQYF8IwcIQnsnGBl5vtXss5Ex5zHhEcNbgBaehyihTRCmxICOnnHabhYKpBjMhEYZpSUSdmVJKlznpkqPcktBEuJRcMSWZgfID1jCYFRLrTDdZKJn2IWoeFZ8ur5pMCyRMixmxqG-pSWuhumUtzfRbDAt9jIeccgIe6FtUSkCaC6YxeiavmIZ6N0kemoTn8hpbQImZmEBFsOlBTR8jSYzKUOqv0rGcnCjEIDFA-cZs5cXV-U1DNEpK4To1jyJlJJbSCLE4TVrlCuiAhA08lC1YxwRENCnZWZoX0gPHzM0MXIkqwI8cqaTEA6gmccAFJ6Y2OTc35UfDFignP6F5Yf70tUcT6HNrocZuXHNlrR6VKU-cS170-mgqG7kyqmPg66iMxK2DUR_8lwueBCSIP008mcNCAhz-GZz08LZ7VWAlRFIc_FlX5R8CixoX-95Qz_sLWgKK7INPhYdlLA96vTmguHnZuVR4eBWT63bFWerHV50WDdVKNvqYjb9ko2_Z6HM2fkX0Vwjb7cnbo8n-weTlp2z8PhsfZOO9bPwm2zv6_frw-Pv-8Y8Pv94dXnO21sPN5ka1uMCk2vdc169aAQrWRdxJgxRqkMRJ6vKO0h3le1KrlMcylvB-BIgRdC34MoGOU_Df0i4kCCzn152VwdNBesOpyDiIhZAdcF8SX1iuu4mvgjjpcC67OrGrzoO86tFOfkpNdB77rDpr0F6R7WEIPiEuxOACs4QQ73-4-V-533IuunSQNy5c3nZWhs920zWA8sPkDvWHP2kTvQc
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A-10.+%E3%82%A2%E3%83%B3%E3%82%B8%E3%82%AA%E3%83%86%E3%83%B3%E3%82%B7%E3%83%B3II%E6%8B%AE%E6%8A%97%E6%80%A7%E3%83%9A%E3%83%97%E3%83%81%E3%83%89%E3%81%AE%E8%87%A8%E5%BA%8A%E5%BF%9C%E7%94%A8&rft.jtitle=%E8%87%A8%E5%BA%8A%E5%8C%96%E5%AD%A6%E3%82%B7%E3%83%B3%E3%83%9D%E3%82%B8%E3%82%A6%E3%83%A0&rft.au=%E4%B8%AD%E4%B8%B8%2C+%E5%85%89%E6%98%AD&rft.au=%E8%90%AC%E4%BB%A3%2C+%E9%9A%86&rft.au=%E6%B3%A2%E5%A4%9A%2C+%E4%B8%88&rft.au=%E4%B8%89%E4%B8%8A%2C+%E6%B4%8B&rft.date=1978&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%87%A8%E5%BA%8A%E5%8C%96%E5%AD%A6%E4%BC%9A&rft.issn=0386-3417&rft.eissn=2187-4085&rft.volume=17&rft.spage=49&rft.epage=53&rft_id=info:doi/10.14921%2Fjscc1971a.17.0_49&rft.externalDocID=article_jscc1971a_17_0_17_49_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0386-3417&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0386-3417&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0386-3417&client=summon